These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 781135)

  • 21. A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide.
    Somerville JE; Cassiano L; Bainbridge B; Cunningham MD; Darveau RP
    J Clin Invest; 1996 Jan; 97(2):359-65. PubMed ID: 8567955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetical control of B-cell responses. III. Requirement for functional mitogenicity of the antigen in thymus-independent specific responses.
    Coutinho A; Gronowicz E
    J Exp Med; 1975 Apr; 141(4):753-60. PubMed ID: 1092788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of the mannan O side-chains to the adjuvant action of lipopolysaccharides.
    Ohta M; Kido N; Hasegawa T; Ito H; Fujii Y; Arakawa Y; Komatsu T; Kato N
    Immunology; 1987 Apr; 60(4):503-7. PubMed ID: 2438205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological activities of chemically modified endotoxins from Vibrio cholerae.
    Raziuddin S
    Biochim Biophys Acta; 1980 Nov; 620(2):193-204. PubMed ID: 7437452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the biological responses induced by lipopolysaccharide and endotoxin of Treponema hyodysenteriae and Treponema innocens.
    Greer JM; Wannemuehler MJ
    Infect Immun; 1989 Mar; 57(3):717-23. PubMed ID: 2917784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dissociation of adjuvant properties of mycobacterial components from mitogenicity, and from the ability to induce the release of mediators from macrophages.
    Rook GA; Stewart-Tull DE
    Immunology; 1976 Sep; 31(3):389-96. PubMed ID: 800406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The endotoxin from S-, R- and M-forms of enteropathogenic E. coli O 149: pyrogenicity, Shwartzman-phenomenon and hypersensitivity (author's transl)].
    Parnas J; Sorensen B
    Zentralbl Bakteriol Orig A; 1975 May; 231(4):426-36. PubMed ID: 1101577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of adjuvanticity and autoantibody inducing capacity of endotoxin and radio-detoxified endotoxin in mice.
    Klimovich VB; Samoilovich MP; Denisova GN; Sirota NS; Schuls TS; Zeludov VI; Bertók L
    Acta Microbiol Hung; 1986; 33(4):311-5. PubMed ID: 3307274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological activities of endotoxins from Yersinia enterocolitica.
    Kanamori M
    Jpn J Microbiol; 1976 Aug; 20(4):273-80. PubMed ID: 978837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The secretory antibody response in milk and bile against fimbriae and LPS in rats monocolonized or immunized in the Peyer's patches with Escherichia coli.
    Dahlgren UI; Wold AE; Hanson LA; Midtvedt T
    Immunology; 1990 Oct; 71(2):295-300. PubMed ID: 1977693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deacylation of bacterial endotoxins by neutrophils and macrophages: early observations and hypotheses.
    Munford RS
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):63-5. PubMed ID: 3713375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological properties of the native and synthetic lipid A of Porphyromonas gingivalis lipopolysaccharide.
    Kumada H; Haishima Y; Watanabe K; Hasegawa C; Tsuchiya T; Tanamoto K; Umemoto T
    Oral Microbiol Immunol; 2008 Feb; 23(1):60-9. PubMed ID: 18173800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities.
    Galanos C; Lüderitz O; Rietschel ET; Westphal O; Brade H; Brade L; Freudenberg M; Schade U; Imoto M; Yoshimura H
    Eur J Biochem; 1985 Apr; 148(1):1-5. PubMed ID: 2579812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serological studies on the Shwartzman phenomenon-like reaction in germ free and conventional mice.
    Imagawa T
    Bull Osaka Med Sch; 1978 Oct; 24(2):39-55. PubMed ID: 391306
    [No Abstract]   [Full Text] [Related]  

  • 35. Biological and chemical characterization of lipopolysaccharide from Selenomonas spp. in human periodontal pockets.
    Kurimoto T; Tachibana C; Suzuki M; Watanabe T
    Infect Immun; 1986 Mar; 51(3):969-71. PubMed ID: 3512446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the pyrogenicity of two different lipopolysaccharides and their lipid A-bovine serum albumin complexes.
    Ogawa Y; Murai T; Kanoh S
    J Pharmacobiodyn; 1986 Sep; 9(9):722-8. PubMed ID: 3540273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The adjuvant action of Escherichia coli lipopolysaccharide and of its lipid fraction on antibody production].
    Grinstein S; Kierszenbaum F; Ferraresi RW
    Rev Immunol Ther Antimicrob; 1966; 30(3):141-9. PubMed ID: 5332425
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative study of biological activities and mitogenic effect of extracts from Haemophilus influenzae type a.
    Raichvarg D; Guenounou M; Brossard C; Agneray J; Alouf JE
    Med Microbiol Immunol; 1980; 168(3):201-10. PubMed ID: 6967559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biologic properties of bacterial lipopolysaccharides treated with chromium chloride.
    Snyder SL; Walker RI; MacVittie TJ; Sheil JM
    Can J Microbiol; 1978 May; 24(5):495-501. PubMed ID: 350361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical structure and biological activity of endotoxins (lipopolysaccharides) and lipid A.
    Rietschel ET
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287(1):73-84. PubMed ID: 1090853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.